Ulrich Neumann, MBA MSc MAMar 8, 20221 minKindness, not indignation for mask-wearers, please.We’re living the COVID comeback, but the immunocompromised among us may still need to wear mask. We need to show kindness, not indignation.
Ulrich Neumann, MBA MSc MAFeb 10, 20221 minMarc Cuban's Cost-PlusMark Cuban's latest venture may shift people's perception on the drug supply chain. That's a welcome opportunity to rethink it.
Ulrich Neumann, MBA MSc MAJan 26, 20221 minCBO report finds claim that drug prices increased "unlikely" The very latest official CBO report now states unequivocally: It's "unlikely" drug net prices have increased, and they declined in Medicare
Ulrich Neumann, MBA MSc MAJan 25, 20221 minThe majority of "drug spending" isn't really on drugs. The majority of "drug spending" isn't really on drugs. When it comes to overall spending on pharmaceuticals, only 37% go to manufacturers.
Ulrich Neumann, MBA MSc MADec 23, 20211 minCMS: Drug prices are not skyrocketing, they declined in 2020Per CMS: Drug prices are not skyrocketing on the list price level and they are in fact declining for yet another year on net prices.